Catalent’s Belgian manufacturing foothold is widening, as the company moves to acquire yet another cell and gene therapy CDMO in the area. Catalent locked in...
Bristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company is...
That didn’t take long. Fujifilm is laying plans for a new manufacturing facility in Watertown, Massachusetts—the second it’s announced in a little over a week....
With the race for COVID-19 vaccines heating up and the cell and gene therapy market booming, contract manufacturers in the viral vector space are quickly...
Less than two months ago, Hitachi Chemicals’ regenerative medicines business adopted the name Minaris to boost brand recognition as a global cell and gene therapy CDMO. Fresh off...
With dozens of approvals expected in the coming years, the cell and gene therapy space has turned into a goldmine for contract manufacturers. But COVID-19...
In the bustling cell and gene therapy space, commercial manufacturing capacity will have a tough time keeping up with the potentially dozens of candidates hitting the...